https://blogs.mercola.com:443/sites/vitalvotes/archive/2019/09/17/cancercausing-chemical-found-in-heartburn-medication.aspxThe U.S. Food and Drug Administration released a press statement last week alerting the public of carcinogens found in ranitidine medications, including those sold under the popular brand name Zantac. According to the FDA, the drugs contain low levelsenCommunityServer 2008.5 SP1 (Debug Build: 31106.3070)https://blogs.mercola.com:443/sites/vitalvotes/archive/2019/09/17/cancercausing-chemical-found-in-heartburn-medication.aspx?ShowAllComments=True#9650989/18/2019 9:30:42 AM24451277-a5aa-4add-96dc-64081bfd86fa:965098rrealrose<p>This is fairly serious stuff unearthed about OTC medications, and not seeing article references so here&#39;s one!  Suzy Cohen discusses this topic further in more detail here: <a rel="nofollow" target="_new" href="https://suzycohen.com/articles/zantac-ndma-carcinogen/">suzycohen.com/.../zantac-ndma-carcinogen</a> &nbsp;</p> <p>And the Bloomberg Businessweek article from Sept 12 (avai. online) is way more detailed, about poorly regulated or even overseen sourcing ingredients from China and other areas in asia leaves the drug makers open for all sorts of potentially dangerous contaminants to enter the US supply train...and then what?? No one seems to have been checking until quite recently. This could break open the drug market in ways the FDA was not looking for? NOT have foreseen? Here&#39;s a link: <a rel="nofollow" target="_new" href="https://www.bloomberg.com/news/features/2019-09-12/how-carcinogen-tainted-generic-drug-valsartan-got-past-the-fda">www.bloomberg.com/.../how-carcinogen-tainted-generic-drug-valsartan-got-past-the-fda</a> </p>